Vault-13

OUP Management Co., LLC

Bala Cynwyd, PA · CIK 1880124 · 13F filing filed 2022-07-19

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$72.7m reported value -44.7% vs Q1 2022
15positions
94.9%in top 10
0 new 0 added 3 reduced 1 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 2,937,615 $14.3m19.69% 19.69% UnchangedShares held: Q3 2021 —, Q4 2021 2.3m, Q1 2022 2.9m, Q2 2022 2.9m
2 PMV PHARMACEUTICALS INC COM PMVP PMVP 989,232 $14.1m19.40% 19.40% UnchangedShares held: Q3 2021 —, Q4 2021 989.2k, Q1 2022 989.2k, Q2 2022 989.2k
3 AEROVATE THERAPEUTICS INC COM COM 603,762 $9.4m12.99% 12.99% UnchangedShares held: Q3 2021 —, Q4 2021 603.8k, Q1 2022 603.8k, Q2 2022 603.8k
4 DICE THERAPEUTICS INC COM COM 536,693 $8.3m11.46% 11.46% UnchangedShares held: Q3 2021 —, Q4 2021 536.7k, Q1 2022 536.7k, Q2 2022 536.7k
5 CYTEIR THERAPEUTICS INC COM COM 2,474,572 $7.4m10.18% 10.18% UnchangedShares held: Q3 2021 —, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
6 IONQ INC COM IONQ IONQ 1,377,597 $6.0m8.30% 8.30% ReducedShares held: Q3 2021 —, Q4 2021 4.1m, Q1 2022 2.3m, Q2 2022 1.4m -941.9k -941,922 -40.6%
7 EVOLV TECHNOLOGIES HLDNGS IN COM CL A EVLV EVLV 1,582,721 $4.2m5.79% 5.79% ReducedShares held: Q3 2021 —, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.6m -238.1k -238,145 -13.1%
8 VOR BIOPHARMA INC COM COM 374,714 $1.9m2.56% 2.56% UnchangedShares held: Q3 2021 —, Q4 2021 374.7k, Q1 2022 374.7k, Q2 2022 374.7k
9 PRECISION BIOSCIENCES INC COM COM 1,123,913 $1.8m2.47% 2.47% UnchangedShares held: Q3 2021 —, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
10 EFFECTOR THERAPEUTICS INC COM COM 1,025,697 $1.5m2.00% 2.00% UnchangedShares held: Q3 2021 —, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
11 LANDOS BIOPHARMA INC COM COM 1,612,764 $1.2m1.62% 1.62% ReducedShares held: Q3 2021 —, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.6m -214.7k -214,714 -11.8%
12 SELECTA BIOSCIENCES INC COM COM 862,543 $1.1m1.56% 1.56% UnchangedShares held: Q3 2021 —, Q4 2021 862.5k, Q1 2022 862.5k, Q2 2022 862.5k
13 GRAPHITE BIO INC COM GRPH GRPH 406,308 $1.1m1.54% 1.54% UnchangedShares held: Q3 2021 —, Q4 2021 406.3k, Q1 2022 406.3k, Q2 2022 406.3k
14 SPERO THERAPEUTICS INC COM SPRO SPRO 249,070 $185.0k0.25% 0.25% UnchangedShares held: Q3 2021 —, Q4 2021 249.1k, Q1 2022 249.1k, Q2 2022 249.1k
15 HOMOLOGY MEDICINES INC COM FIXX FIXX 64,000 $126.0k0.17% 0.17% UnchangedShares held: Q3 2021 —, Q4 2021 64.0k, Q1 2022 64.0k, Q2 2022 64.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
SERA PROGNOSTICS INC SERA SERA 337,505 $1.3m337.5k shares